Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2020-07-23 2017-03-13
Drug Identification Number 02230946 02230946
Brand name QUADRACEL QUADRACEL
Common or Proper name Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine QUADRACEL®
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients DIPHTHERIA TOXOID FILAMENTOUS HAEMAGGLUTININ FIMBRIAE INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT PERTACTIN PERTUSSIS TOXOID TETANUS TOXOID DIPHTHERIA TOXOID FILAMENTOUS HAEMAGGLUTININ FIMBRIAE INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT PERTACTIN PERTUSSIS TOXOID TETANUS TOXOID
Strength(s) 15 LF / 0.5 ML 20 MCG / 0.5 ML 5 MCG / 0.5 ML 8 UNIT / 0.5 ML 3 MCG / 0.5 ML 20 MCG / 0.5 ML 5 LF / 0.5 ML 15 LF / 0.5 ML 20 MCG / 0.5 ML 5 MCG / 0.5 ML 8 UNIT / 0.5 ML 3 MCG / 0.5 ML 20 MCG / 0.5 ML 5 LF / 0.5 ML
Dosage form(s) Suspension Suspension
Route of administration Intramuscular Intramuscular
Packaging size 5 x 0.5 mL vials / 5 fioles de 0,5 mL 5 x 0.5 mL vials / 5 fioles de 0,5 mL
ATC code J07CA J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2015-05-31 2015-05-31
Actual start date
Estimated end date Unknown Unknown
Actual end date 2017-08-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Supply status will be updated when more information becomes available. The impact that this shortage may have on availability may differ depending on the public immunization program offered in each province and territory. For more information on the potential impacts, if any, in your province or territory please contact your local public health department. Supply status will be updated when more information becomes available. The impact that this shortage may have on availability may differ depending on the public immunization program offered in each province and territory. For more information on the potential impacts, if any, in your province or territory please contact your local public health department.
Health Canada comments